S. 5349119th CongressRead twice and referred to the Committee on Armed Services.

DEPOTS Act

Introduced: Aug 6, 2026

Latest action: Aug 6, 2026

Latest Action

Read twice and referred to the Committee on Armed Services.

Congress.gov Bill Record ↗Official Bill Text ↗

Primary Sponsors

Cosponsors

Recorded Actions

Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Summary Ready

What this bill does

The Defense Expenditure Planning for Optimizing Throughput and Sustainment Act of 2026 (or the DEPOTS Act) gives the Department of Defense (DOD) the authority to clear internal accounting charges tied to military depot and arsenal assets when federal orders change a facility's mission and cause those assets to stop bringing in revenue.

Who it affects

* **Department of Defense Leadership:** The Secretary of Defense and Secretaries of individual military departments (such as the Army, Navy, or Air Force) who are granted permission to manage these financial accounting adjustments. * **Military Depots and Arsenals:** Facilities that undergo federally directed mission changes that lead to unused or non-revenue-generating capital assets. * **Commercial Contractors:** External businesses working with the military are unaffected, as the bill explicitly protects payments owed to them.

What would change

The Secretary of Defense (or a delegated military department secretary) would be permitted to write off internal DOD financial burdens—specifically internal debts or remaining asset depreciation—for capital equipment or facilities at depots and arsenals. This option applies when those assets no longer produce revenue due to federally mandated mission realignments.

Money or funding

The bill does not appropriate new taxpayer money or alter external funding. Instead, it adjusts internal DOD accounting balances. However, the bill creates a specific requirement for these accounting adjustments: any write-off must be handled in a way that recovers prior cash spent from military revolving funds.

Important exceptions or limits

* **Internal limits only:** This authority is strictly limited to internal military accounting balances. * **No contractor impact:** The bill specifically forbids using this authority to cancel or lower payments owed to commercial contractors. * **Condition for use:** Write-offs are only allowed for assets that stop generating revenue as a result of federally directed mission realignments.

Plain-English bottom line

This bill permits the military to clean up its internal accounting records by erasing debts or depreciation charges on equipment at depots and arsenals when official mission changes render those assets unproductive, as long as internal revolving fund cash is recovered and outside contractors are still paid.

This summary was generated by AI from the official bill text. It is intended to make legislation easier to understand and does not replace the original legal language.

AI model: gemini-3.6-flashUpdated: Oct 3, 2026Review official bill text ↗

Official Summary

Official legislative summary associated with this bill.

No official summary is currently available.

Primary Sponsors

Members listed as primary sponsors of this legislation.

John Cornyn

Republican • Texas

Primary Sponsor

Aug 6, 2026

Cosponsors

Members who joined this legislation as cosponsors.

No cosponsors found.

Recorded Actions

Official legislative actions recorded for this measure.

Aug 6, 2026

Read twice and referred to the Committee on Armed Services.

Official source ↗

10000Aug 6, 2026

Introduced in Senate

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify S. 5349. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION

Registrant: EMERGENT STRATEGIES

1st Quarter (Jan 1 - Mar 31)

Apr 21, 2025

Reported lobbying issue

Trade (domestic/foreign): Issues related to CHIPS implementation Medical/Disease Research/Clinical Labs: Health tax issues and trade Issues related to Small Business Innovation Research Program PAHPA Reauthorization Taxation/Internal Revenue Code: Issues relating to health tax issues and trade Computer Industry: Issues related to health data privacy Medicare/Medicaid: Issues on legislation pertaining to H.R.1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023 Issues on legislation pertaining to S.5349 Ensuring Patient Access to Critical Breakthrough Products Act of 2024 Issues related to transitional coverage of emerging technologies

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $45,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION

Registrant: EMERGENT STRATEGIES

1st Quarter (Jan 1 - Mar 31)

Apr 21, 2025

Reported lobbying issue

Medical/Disease Research/Clinical Labs: Health tax issues and trade Issues related to Small Business Innovation Research Program PAHPA Reauthorization Taxation/Internal Revenue Code: Issues relating to health tax issues and trade Computer Industry: Issues related to health data privacy Trade (domestic/foreign): Issues related to CHIPS implementation Medicare/Medicaid: Issues on legislation pertaining to H.R.1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023 Issues on legislation pertaining to S.5349 Ensuring Patient Access to Critical Breakthrough Products Act of 2024 Issues related to transitional coverage of emerging technologies

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $30,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

EDWARDS LIFESCIENCES LLC

Registrant: EDWARDS LIFESCIENCES, LLC

1st Quarter (Jan 1 - Mar 31)

Apr 18, 2025

Reported lobbying issue

Health Issues: Ensuring Patient Access to Critical Breakthrough Products (H.R.1691 S.5349) Transitional Coverage for Emerging Technologies (TCET) Guidance Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization for 2022/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development Medicare/Medicaid: CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.1691/S.5349) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development Taxation/Internal Revenue Code: Corporate Tax Reform Proposals Trade (domestic/foreign): Tariffs Veterans: Veterans Access to MedTech

Government entities reported: Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) HOUSE OF REPRESENTATIVES SENATE Health & Human Services, Dept of (HHS)

Reported filing-period amount: $350,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

NOVOCURE INC.

Registrant: NOVOCURE INC.

1st Quarter (Jan 1 - Mar 31)

Apr 16, 2025

Reported lobbying issue

Medicare/Medicaid: General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024. Veterans: Veterans Affairs / Veterans Health Administration (VHA) issues.

Government entities reported: Health & Human Services, Dept of (HHS) HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $110,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

Discussion notificationsSign in to subscribe

No comments yet. Start the conversation.